Product NDC: | 51808-103 |
Proprietary Name: | i 123 MIBG |
Non Proprietary Name: | i 123 MIBG |
Active Ingredient(s): | 25 mCi/1 & nbsp; i 123 MIBG |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51808-103 |
Labeler Name: | AnazaoHealth Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20120523 |
Package NDC: | 51808-103-01 |
Package Description: | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CONTAINER (51808-103-01) |
NDC Code | 51808-103-01 |
Proprietary Name | i 123 MIBG |
Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CONTAINER (51808-103-01) |
Product NDC | 51808-103 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | i 123 MIBG |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120523 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | AnazaoHealth Corporation |
Substance Name | IOBENGUANE SULFATE I-123 |
Strength Number | 25 |
Strength Unit | mCi/1 |
Pharmaceutical Classes |